Fuller & Thaler Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-1,400
| Closed | -$243K | – | 751 |
|
|
2015
Q1 | $243K | Sell |
1,400
-1,200
| -46% | -$208K | 0.01% | 384 |
|
|
2014
Q4 | $481K | Buy |
2,600
+400
| +18% | +$74K | 0.02% | 320 |
|
|
2014
Q3 | $365K | Sell |
2,200
-200
| -8% | -$33.2K | 0.02% | 360 |
|
|
2014
Q2 | $375K | Sell |
2,400
-3,100
| -56% | -$484K | 0.02% | 354 |
|
|
2014
Q1 | $837K | Buy |
5,500
+4,200
| +323% | +$639K | 0.04% | 276 |
|
|
2013
Q4 | $173K | Buy |
1,300
+500
| +63% | +$66.5K | 0.01% | 424 |
|
|
2013
Q3 | $93K | Buy |
+800
| New | +$93K | 0.01% | 519 |
|